An Elderly Case of Paraneoplastic Anti-NMDA Receptor Encephalitis Associated with Small-cell Lung Cancer Expressing NR1 Subunits

A 61-year-old Japanese man presented with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. NR1 antibodies were detected in his cerebrospinal fluid. Chest computed tomography revealed lung tumor. The patient was diagnosed with paraneoplastic anti-NMDAR encephalitis associated with lung cancer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal Medicine 2020/09/15, Vol.59(18), pp.2307-2309
Hauptverfasser: Kobayashi, Yuya, Sato, Mitsuto, Kinoshita, Michiaki, Kakizawa, Masaki, Higuchi, Kayoko, Yamada, Mitsunori, Kodaira, Minori, Sekijima, Yoshiki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2309
container_issue 18
container_start_page 2307
container_title Internal Medicine
container_volume 59
creator Kobayashi, Yuya
Sato, Mitsuto
Kinoshita, Michiaki
Kakizawa, Masaki
Higuchi, Kayoko
Yamada, Mitsunori
Kodaira, Minori
Sekijima, Yoshiki
description A 61-year-old Japanese man presented with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. NR1 antibodies were detected in his cerebrospinal fluid. Chest computed tomography revealed lung tumor. The patient was diagnosed with paraneoplastic anti-NMDAR encephalitis associated with lung cancer and treated with two cycles of intravenous high-dose methylprednisolone and one cycle of intravenous immunoglobulin. However, he died one year later without improvement. An autopsy confirmed small-cell lung cancer (SCLC). Immunohistochemistry revealed the expression of NR1 subunits in the tumor cells, suggesting that SCLC may trigger NR1 autoimmunity though the expression of NR1 subunits as onconeural antigens, expanding the phenotypic spectrum of paraneoplastic neurological syndrome associated with SCLC.
doi_str_mv 10.2169/internalmedicine.4860-20
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7578603</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2409639074</sourcerecordid><originalsourceid>FETCH-LOGICAL-c610t-1daea7f00cb2fc153e1a5cd8503d0cf74aa55fcc60475936e321cb0e5cb44daa3</originalsourceid><addsrcrecordid>eNplkVFv0zAUhSMEYt3gLyBLvPCSYcdxEr8gVV0ZSGVDGzxbt85N68p1gu0Ae-On46ilgvFybdnfPfY9J8sIo5cFq-Rb4yJ6B3aPrdHG4WXZVDQv6JNsxngp87rg4mk2o5I1eZHKWXYewo5S3tSyeJ6d8aKUvBHVLPs1d2RpW_T2gSwgIOk78hk8OOwHCyEaTeYumvzm09Wc3KHGIfaeLF3abMGaaAKZh9BrAxFb8sPELbnfg7W5RmvJanSbJJvo1PNz8BiCSSc3d4zcj-vRmRheZM86sAFfHteL7Ov75ZfFh3x1e_1xMV_lumI05qwFhLqjVK-LTjPBkYHQbSMob6nu6hJAiE7ripa1kLxCXjC9pij0uixbAH6RvTvoDuM62abRRQ9WDd7swT-oHoz698aZrdr031Ut6mQuTwJvjgK-_zZiiGpvwjTl5NUYVFFSWXFJ6zKhrx-hu36c8pqospaVkFWVqOZAad-H4LE7fYZRNcWsHsespphVQVPrq7-HOTX-yTUBtwdgFyJs8ASAT4la_F9ZSMWaqR6fOJF6C16h478BWE7IxQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2447965966</pqid></control><display><type>article</type><title>An Elderly Case of Paraneoplastic Anti-NMDA Receptor Encephalitis Associated with Small-cell Lung Cancer Expressing NR1 Subunits</title><source>J-STAGE Free</source><source>MEDLINE</source><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Kobayashi, Yuya ; Sato, Mitsuto ; Kinoshita, Michiaki ; Kakizawa, Masaki ; Higuchi, Kayoko ; Yamada, Mitsunori ; Kodaira, Minori ; Sekijima, Yoshiki</creator><creatorcontrib>Kobayashi, Yuya ; Sato, Mitsuto ; Kinoshita, Michiaki ; Kakizawa, Masaki ; Higuchi, Kayoko ; Yamada, Mitsunori ; Kodaira, Minori ; Sekijima, Yoshiki</creatorcontrib><description>A 61-year-old Japanese man presented with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. NR1 antibodies were detected in his cerebrospinal fluid. Chest computed tomography revealed lung tumor. The patient was diagnosed with paraneoplastic anti-NMDAR encephalitis associated with lung cancer and treated with two cycles of intravenous high-dose methylprednisolone and one cycle of intravenous immunoglobulin. However, he died one year later without improvement. An autopsy confirmed small-cell lung cancer (SCLC). Immunohistochemistry revealed the expression of NR1 subunits in the tumor cells, suggesting that SCLC may trigger NR1 autoimmunity though the expression of NR1 subunits as onconeural antigens, expanding the phenotypic spectrum of paraneoplastic neurological syndrome associated with SCLC.</description><identifier>ISSN: 0918-2918</identifier><identifier>EISSN: 1349-7235</identifier><identifier>DOI: 10.2169/internalmedicine.4860-20</identifier><identifier>PMID: 32493856</identifier><language>eng</language><publisher>Japan: The Japanese Society of Internal Medicine</publisher><subject>anti-N-methyl-D-aspartate receptor ; Anti-N-Methyl-D-Aspartate Receptor Encephalitis - complications ; Anti-N-Methyl-D-Aspartate Receptor Encephalitis - diagnosis ; Antibodies - therapeutic use ; Antigens ; Autoantibodies ; Autoimmunity ; Autopsy ; Case Report ; Cerebrospinal fluid ; Computed tomography ; Encephalitis ; Glutamic acid receptors ; Glutamic acid receptors (ionotropic) ; Humans ; Immunoglobulins - therapeutic use ; Immunoglobulins, Intravenous - therapeutic use ; Immunohistochemistry ; Internal medicine ; Intravenous administration ; Lung cancer ; Lung Neoplasms - complications ; Lung Neoplasms - drug therapy ; Male ; Methylprednisolone ; Methylprednisolone - therapeutic use ; Middle Aged ; N-Methyl-D-aspartic acid receptors ; NMDAR ; paraneoplastic syndrome ; Receptors, N-Methyl-D-Aspartate - immunology ; SCLC ; small cell lung cancer ; Small cell lung carcinoma ; Small Cell Lung Carcinoma - complications ; Small Cell Lung Carcinoma - drug therapy ; Tumor cells</subject><ispartof>Internal Medicine, 2020/09/15, Vol.59(18), pp.2307-2309</ispartof><rights>2020 by The Japanese Society of Internal Medicine</rights><rights>Copyright Japan Science and Technology Agency 2020</rights><rights>Copyright © 2020 by The Japanese Society of Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c610t-1daea7f00cb2fc153e1a5cd8503d0cf74aa55fcc60475936e321cb0e5cb44daa3</citedby><cites>FETCH-LOGICAL-c610t-1daea7f00cb2fc153e1a5cd8503d0cf74aa55fcc60475936e321cb0e5cb44daa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578603/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578603/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,1883,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32493856$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kobayashi, Yuya</creatorcontrib><creatorcontrib>Sato, Mitsuto</creatorcontrib><creatorcontrib>Kinoshita, Michiaki</creatorcontrib><creatorcontrib>Kakizawa, Masaki</creatorcontrib><creatorcontrib>Higuchi, Kayoko</creatorcontrib><creatorcontrib>Yamada, Mitsunori</creatorcontrib><creatorcontrib>Kodaira, Minori</creatorcontrib><creatorcontrib>Sekijima, Yoshiki</creatorcontrib><title>An Elderly Case of Paraneoplastic Anti-NMDA Receptor Encephalitis Associated with Small-cell Lung Cancer Expressing NR1 Subunits</title><title>Internal Medicine</title><addtitle>Intern. Med.</addtitle><description>A 61-year-old Japanese man presented with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. NR1 antibodies were detected in his cerebrospinal fluid. Chest computed tomography revealed lung tumor. The patient was diagnosed with paraneoplastic anti-NMDAR encephalitis associated with lung cancer and treated with two cycles of intravenous high-dose methylprednisolone and one cycle of intravenous immunoglobulin. However, he died one year later without improvement. An autopsy confirmed small-cell lung cancer (SCLC). Immunohistochemistry revealed the expression of NR1 subunits in the tumor cells, suggesting that SCLC may trigger NR1 autoimmunity though the expression of NR1 subunits as onconeural antigens, expanding the phenotypic spectrum of paraneoplastic neurological syndrome associated with SCLC.</description><subject>anti-N-methyl-D-aspartate receptor</subject><subject>Anti-N-Methyl-D-Aspartate Receptor Encephalitis - complications</subject><subject>Anti-N-Methyl-D-Aspartate Receptor Encephalitis - diagnosis</subject><subject>Antibodies - therapeutic use</subject><subject>Antigens</subject><subject>Autoantibodies</subject><subject>Autoimmunity</subject><subject>Autopsy</subject><subject>Case Report</subject><subject>Cerebrospinal fluid</subject><subject>Computed tomography</subject><subject>Encephalitis</subject><subject>Glutamic acid receptors</subject><subject>Glutamic acid receptors (ionotropic)</subject><subject>Humans</subject><subject>Immunoglobulins - therapeutic use</subject><subject>Immunoglobulins, Intravenous - therapeutic use</subject><subject>Immunohistochemistry</subject><subject>Internal medicine</subject><subject>Intravenous administration</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - complications</subject><subject>Lung Neoplasms - drug therapy</subject><subject>Male</subject><subject>Methylprednisolone</subject><subject>Methylprednisolone - therapeutic use</subject><subject>Middle Aged</subject><subject>N-Methyl-D-aspartic acid receptors</subject><subject>NMDAR</subject><subject>paraneoplastic syndrome</subject><subject>Receptors, N-Methyl-D-Aspartate - immunology</subject><subject>SCLC</subject><subject>small cell lung cancer</subject><subject>Small cell lung carcinoma</subject><subject>Small Cell Lung Carcinoma - complications</subject><subject>Small Cell Lung Carcinoma - drug therapy</subject><subject>Tumor cells</subject><issn>0918-2918</issn><issn>1349-7235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkVFv0zAUhSMEYt3gLyBLvPCSYcdxEr8gVV0ZSGVDGzxbt85N68p1gu0Ae-On46ilgvFybdnfPfY9J8sIo5cFq-Rb4yJ6B3aPrdHG4WXZVDQv6JNsxngp87rg4mk2o5I1eZHKWXYewo5S3tSyeJ6d8aKUvBHVLPs1d2RpW_T2gSwgIOk78hk8OOwHCyEaTeYumvzm09Wc3KHGIfaeLF3abMGaaAKZh9BrAxFb8sPELbnfg7W5RmvJanSbJJvo1PNz8BiCSSc3d4zcj-vRmRheZM86sAFfHteL7Ov75ZfFh3x1e_1xMV_lumI05qwFhLqjVK-LTjPBkYHQbSMob6nu6hJAiE7ripa1kLxCXjC9pij0uixbAH6RvTvoDuM62abRRQ9WDd7swT-oHoz698aZrdr031Ut6mQuTwJvjgK-_zZiiGpvwjTl5NUYVFFSWXFJ6zKhrx-hu36c8pqospaVkFWVqOZAad-H4LE7fYZRNcWsHsespphVQVPrq7-HOTX-yTUBtwdgFyJs8ASAT4la_F9ZSMWaqR6fOJF6C16h478BWE7IxQ</recordid><startdate>20200915</startdate><enddate>20200915</enddate><creator>Kobayashi, Yuya</creator><creator>Sato, Mitsuto</creator><creator>Kinoshita, Michiaki</creator><creator>Kakizawa, Masaki</creator><creator>Higuchi, Kayoko</creator><creator>Yamada, Mitsunori</creator><creator>Kodaira, Minori</creator><creator>Sekijima, Yoshiki</creator><general>The Japanese Society of Internal Medicine</general><general>Japan Science and Technology Agency</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200915</creationdate><title>An Elderly Case of Paraneoplastic Anti-NMDA Receptor Encephalitis Associated with Small-cell Lung Cancer Expressing NR1 Subunits</title><author>Kobayashi, Yuya ; Sato, Mitsuto ; Kinoshita, Michiaki ; Kakizawa, Masaki ; Higuchi, Kayoko ; Yamada, Mitsunori ; Kodaira, Minori ; Sekijima, Yoshiki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c610t-1daea7f00cb2fc153e1a5cd8503d0cf74aa55fcc60475936e321cb0e5cb44daa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>anti-N-methyl-D-aspartate receptor</topic><topic>Anti-N-Methyl-D-Aspartate Receptor Encephalitis - complications</topic><topic>Anti-N-Methyl-D-Aspartate Receptor Encephalitis - diagnosis</topic><topic>Antibodies - therapeutic use</topic><topic>Antigens</topic><topic>Autoantibodies</topic><topic>Autoimmunity</topic><topic>Autopsy</topic><topic>Case Report</topic><topic>Cerebrospinal fluid</topic><topic>Computed tomography</topic><topic>Encephalitis</topic><topic>Glutamic acid receptors</topic><topic>Glutamic acid receptors (ionotropic)</topic><topic>Humans</topic><topic>Immunoglobulins - therapeutic use</topic><topic>Immunoglobulins, Intravenous - therapeutic use</topic><topic>Immunohistochemistry</topic><topic>Internal medicine</topic><topic>Intravenous administration</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - complications</topic><topic>Lung Neoplasms - drug therapy</topic><topic>Male</topic><topic>Methylprednisolone</topic><topic>Methylprednisolone - therapeutic use</topic><topic>Middle Aged</topic><topic>N-Methyl-D-aspartic acid receptors</topic><topic>NMDAR</topic><topic>paraneoplastic syndrome</topic><topic>Receptors, N-Methyl-D-Aspartate - immunology</topic><topic>SCLC</topic><topic>small cell lung cancer</topic><topic>Small cell lung carcinoma</topic><topic>Small Cell Lung Carcinoma - complications</topic><topic>Small Cell Lung Carcinoma - drug therapy</topic><topic>Tumor cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kobayashi, Yuya</creatorcontrib><creatorcontrib>Sato, Mitsuto</creatorcontrib><creatorcontrib>Kinoshita, Michiaki</creatorcontrib><creatorcontrib>Kakizawa, Masaki</creatorcontrib><creatorcontrib>Higuchi, Kayoko</creatorcontrib><creatorcontrib>Yamada, Mitsunori</creatorcontrib><creatorcontrib>Kodaira, Minori</creatorcontrib><creatorcontrib>Sekijima, Yoshiki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Internal Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kobayashi, Yuya</au><au>Sato, Mitsuto</au><au>Kinoshita, Michiaki</au><au>Kakizawa, Masaki</au><au>Higuchi, Kayoko</au><au>Yamada, Mitsunori</au><au>Kodaira, Minori</au><au>Sekijima, Yoshiki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An Elderly Case of Paraneoplastic Anti-NMDA Receptor Encephalitis Associated with Small-cell Lung Cancer Expressing NR1 Subunits</atitle><jtitle>Internal Medicine</jtitle><addtitle>Intern. Med.</addtitle><date>2020-09-15</date><risdate>2020</risdate><volume>59</volume><issue>18</issue><spage>2307</spage><epage>2309</epage><pages>2307-2309</pages><issn>0918-2918</issn><eissn>1349-7235</eissn><abstract>A 61-year-old Japanese man presented with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. NR1 antibodies were detected in his cerebrospinal fluid. Chest computed tomography revealed lung tumor. The patient was diagnosed with paraneoplastic anti-NMDAR encephalitis associated with lung cancer and treated with two cycles of intravenous high-dose methylprednisolone and one cycle of intravenous immunoglobulin. However, he died one year later without improvement. An autopsy confirmed small-cell lung cancer (SCLC). Immunohistochemistry revealed the expression of NR1 subunits in the tumor cells, suggesting that SCLC may trigger NR1 autoimmunity though the expression of NR1 subunits as onconeural antigens, expanding the phenotypic spectrum of paraneoplastic neurological syndrome associated with SCLC.</abstract><cop>Japan</cop><pub>The Japanese Society of Internal Medicine</pub><pmid>32493856</pmid><doi>10.2169/internalmedicine.4860-20</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-2918
ispartof Internal Medicine, 2020/09/15, Vol.59(18), pp.2307-2309
issn 0918-2918
1349-7235
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7578603
source J-STAGE Free; MEDLINE; PubMed Central Open Access; PubMed Central
subjects anti-N-methyl-D-aspartate receptor
Anti-N-Methyl-D-Aspartate Receptor Encephalitis - complications
Anti-N-Methyl-D-Aspartate Receptor Encephalitis - diagnosis
Antibodies - therapeutic use
Antigens
Autoantibodies
Autoimmunity
Autopsy
Case Report
Cerebrospinal fluid
Computed tomography
Encephalitis
Glutamic acid receptors
Glutamic acid receptors (ionotropic)
Humans
Immunoglobulins - therapeutic use
Immunoglobulins, Intravenous - therapeutic use
Immunohistochemistry
Internal medicine
Intravenous administration
Lung cancer
Lung Neoplasms - complications
Lung Neoplasms - drug therapy
Male
Methylprednisolone
Methylprednisolone - therapeutic use
Middle Aged
N-Methyl-D-aspartic acid receptors
NMDAR
paraneoplastic syndrome
Receptors, N-Methyl-D-Aspartate - immunology
SCLC
small cell lung cancer
Small cell lung carcinoma
Small Cell Lung Carcinoma - complications
Small Cell Lung Carcinoma - drug therapy
Tumor cells
title An Elderly Case of Paraneoplastic Anti-NMDA Receptor Encephalitis Associated with Small-cell Lung Cancer Expressing NR1 Subunits
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T21%3A00%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20Elderly%20Case%20of%20Paraneoplastic%20Anti-NMDA%20Receptor%20Encephalitis%20Associated%20with%20Small-cell%20Lung%20Cancer%20Expressing%20NR1%20Subunits&rft.jtitle=Internal%20Medicine&rft.au=Kobayashi,%20Yuya&rft.date=2020-09-15&rft.volume=59&rft.issue=18&rft.spage=2307&rft.epage=2309&rft.pages=2307-2309&rft.issn=0918-2918&rft.eissn=1349-7235&rft_id=info:doi/10.2169/internalmedicine.4860-20&rft_dat=%3Cproquest_pubme%3E2409639074%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2447965966&rft_id=info:pmid/32493856&rfr_iscdi=true